Sarath Ramachandran, Nikolai Makukhin, Kevin Haubrich, Manjula Nagala, Beth Forrester, Dylan M. Lynch, Ryan Casement, Andrea Testa, Elvira Bruno, Rosaria Gitto and Alessio Ciulli

Nat Commun, 2023, 14
DOI: 10.1038/s41467-023-41894-3

Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy

Wenda Zhang, Jianpeng Guo, Shanshan Li, Ting Ma, Dingqiao Xu, Chao Han, Feiyan Liu, Wenying Yu and Lingyi Kong

Sci Rep, 2017, 7
DOI: 10.1038/srep46352

Targeting STAT3 in cancer and autoimmune diseases

Tohid Gharibi, Zohreh Babaloo, Arezoo Hosseini, Meghdad Abdollahpour-alitappeh, Vida Hashemi, Faroogh Marofi, Kazem Nejati and Behzad Baradaran

European Journal of Pharmacology, 2020, 878, 173107
DOI: 10.1016/j.ejphar.2020.173107

Pentafluorophosphato‐Phenylalanines: Amphiphilic Phosphotyrosine Mimetics Displaying Fluorine‐Specific Protein Interactions

Matteo Accorsi, Markus Tiemann, Leon Wehrhan, Lauren M. Finn, Ruben Cruz, Max Rautenberg, Franziska Emmerling, Joachim Heberle, Bettina G. Keller and Jörg Rademann

Angew Chem Int Ed, 2022, 61
DOI: 10.1002/anie.202203579

Efficient parameterization of torsional terms for force fields

Steven K. Burger, Paul W. Ayers and Jeremy Schofield

J Comput Chem, 2014, 35, 1438
DOI: 10.1002/jcc.23636

Sequence analysis of the Ras-MAPK pathway genes SOS1, EGFR & GRB2 in silver foxes (Vulpes vulpes): candidate genes for hereditary hyperplastic gingivitis

Jo-Anna B. J. Clark, Sara J. Tully and H. Dawn Marshall

Genetica, 2014, 142, 517
DOI: 10.1007/s10709-014-9798-x

Strategies and Approaches of Targeting STAT3 for Cancer Treatment

Steffanie L. Furtek, Donald S. Backos, Christopher J. Matheson and Philip Reigan

ACS Chem. Biol., 2016, 11, 308
DOI: 10.1021/acschembio.5b00945

Mild C(sp)–H functionalization of dihydrosanguinarine and dihydrochelerythrine for development of highly cytotoxic derivatives

Adriana Romo-Pérez, Luis Demetrio Miranda, Alma D. Chávez-Blanco, Alfonso Dueñas-González, María del Rayo Camacho-Corona, Alejandrina Acosta-Huerta and Abraham García

European Journal of Medicinal Chemistry, 2017, 138, 1
DOI: 10.1016/j.ejmech.2017.06.021

Synthesis and Cytotoxicity Evaluation of Novel Coumarin–Palladium(II) Complexes against Human Cancer Cell Lines

Edina H. Avdović, Marko Antonijević, Dušica Simijonović, Sunčica Roca, Dražen Vikić Topić, Nađa Grozdanić, Tatjana Stanojković, Ivana Radojević, Radiša Vojinović and Zoran Marković

Pharmaceuticals, 2022, 16, 49
DOI: 10.3390/ph16010049

SH2 Ligand-Like Effects of Second Cytosolic Domain of Na/K-ATPase α1 Subunit on Src Kinase

Moumita Banerjee, Qiming Duan, Zijian Xie and Jung Weon Lee

PLoS ONE, 2015, 10, e0142119
DOI: 10.1371/journal.pone.0142119

Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3

Xuebao Wang, Qin He, Kaiqi Wu, Taoning Guo, Xuze Du, Huan Zhang, Longcheng Fang, Nan Zheng, Qihong Zhang and Faqing Ye

European Journal of Medicinal Chemistry, 2019, 179, 218
DOI: 10.1016/j.ejmech.2019.06.017

Optimization of Phosphotyrosine Peptides that Target the SH2 Domain of SOCS1 and Block Substrate Ubiquitination

Hao Chen, Yuntong Wu, Kunlun Li, Iain Currie, Narelle Keating, Farhad Dehkhoda, Christoph Grohmann, Jeffrey J. Babon, Sandra E. Nicholson and Brad E. Sleebs

ACS Chem. Biol., 2022, 17, 449
DOI: 10.1021/acschembio.1c00884

Design, synthesis and evaluation of XZH-5 analogues as STAT3 inhibitors

Philias Daka, Aiguo Liu, Chamini Karunaratne, Erika Csatary, Cameron Williams, Hui Xiao, Jiayuh Lin, Zhenghu Xu, Richard C. Page and Hong Wang

Bioorganic & Medicinal Chemistry, 2015, 23, 1348
DOI: 10.1016/j.bmc.2015.01.025

Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a

Nagarajan Elumalai, Angela Berg, Kalaiselvi Natarajan, Andrej Scharow and Thorsten Berg

Angew Chem Int Ed, 2015, 54, 4758
DOI: 10.1002/anie.201410672

The STAT5b Linker Domain Mediates the Selectivity of Catechol Bisphosphates for STAT5b over STAT5a

Julian Gräb, Angela Berg, Linda Blechschmidt, Barbara Klüver, Stefan Rubner, Darwin Y. Fu, Jens Meiler, Martin Gräber and Thorsten Berg

ACS Chem. Biol., 2019, 14, 796
DOI: 10.1021/acschembio.9b00137

Repurposing L-Menthol for Systems Medicine and Cancer Therapeutics? L-Menthol Induces Apoptosis through Caspase 10 and by Suppressing HSP90

Uzma Faridi, Sunita S. Dhawan, Shaifali Pal, Sanchita Gupta, Ashutosh K. Shukla, Mahendra P. Darokar, Ashok Sharma and Ajit K. Shasany

OMICS: A Journal of Integrative Biology, 2016, 20, 53
DOI: 10.1089/omi.2015.0118

Probing SH2-domains using Inhibitor Affinity Purification (IAP)

Michael Höfener, Stephanie Heinzlmeir, Bernhard Kuster and Norbert Sewald

Proteome Sci, 2014, 12
DOI: 10.1186/1477-5956-12-41

STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma

Mingjing Jiang and Bo Li

Cells, 2022, 11, 3131
DOI: 10.3390/cells11193131

Synthesis of Grb2 SH2 Domain Proteins for Mirror-Image Screening Systems

Taro Noguchi, Hiroyuki Ishiba, Kaori Honda, Yasumitsu Kondoh, Hiroyuki Osada, Hiroaki Ohno, Nobutaka Fujii and Shinya Oishi

Bioconjugate Chem., 2017, 28, 609
DOI: 10.1021/acs.bioconjchem.6b00692

Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3

Lin Deng, Jianshan Mo, Yi Zhang, Keren Peng, Huaxuan Li, Shumin Ouyang, Zongbo Feng, Wei Fang, Jianwei Wei, Deqin Rong, Xiaolei Zhang and Yuanxiang Wang

J. Med. Chem., 2022, 65, 13094
DOI: 10.1021/acs.jmedchem.2c00940

SHIP2: Structure, Function and Inhibition

Mark P. Thomas, Christophe Erneux and Barry V. L. Potter

ChemBioChem, 2017, 18, 233
DOI: 10.1002/cbic.201600541

Inhibition of the STAT3 Protein by a Dinuclear Macrocyclic Complex

Lígia M. Mesquita, Federico Herrera, Catarina V. Esteves, Pedro Lamosa, Vânia André, Pedro Mateus and Rita Delgado

Inorg. Chem., 2016, 55, 3589
DOI: 10.1021/acs.inorgchem.6b00116

STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy

Ping-Lian Yang, Lu-Xin Liu, En-Min Li and Li-Yan Xu

Cancers, 2020, 12, 2459
DOI: 10.3390/cancers12092459

Targeting the Grb2 cSH3 domain: Design, synthesis and biological evaluation of the first series of modulators

Marianna Bufano, Michela Puxeddu, Marianna Nalli, Giuseppe La Regina, Angelo Toto, Francesca Romana Liberati, Alessio Paone, Francesca Cutruzzolà, Domiziana Masci, Chiara Bigogno, Giulio Dondio, Romano Silvestri, Stefano Gianni and Antonio Coluccia

Bioorganic Chemistry, 2023, 138, 106607
DOI: 10.1016/j.bioorg.2023.106607

HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms

C-H Chen, W-H Chang, K-Y Su, W-H Ku, G-C Chang, Q-S Hong, Y-J Hsiao, H-C Chen, H-Y Chen, R Wu, P-C Yang, J J W Chen and S-L Yu

Oncogene, 2016, 35, 5674
DOI: 10.1038/onc.2016.106

In silico Spleen Tyrosine Kinase Inhibitor Screening by ChooseLD

Hideaki Umeyama, Mitsuo Iwadate and Y-h. Taguchi

IPSJ Transactions on Bioinformatics, 2015, 8, 14
DOI: 10.2197/ipsjtbio.8.14

Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target

Gabrielle M. Watson, Menachem J. Gunzburg, Nigus D. Ambaye, William A. H. Lucas, Daouda A. Traore, Ketav Kulkarni, Katie M. Cergol, Richard J. Payne, Santosh Panjikar, Stephanie C. Pero, Patrick Perlmutter, Matthew C. J. Wilce and Jacqueline A. Wilce

J. Med. Chem., 2015, 58, 7707
DOI: 10.1021/acs.jmedchem.5b00609

Functional characterization of phospholipase C-γ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder

Claudia Walliser, Martin Wist, Elisabeth Hermkes, Yuan Zhou, Anja Schade, Jennifer Haas, Julia Deinzer, Laurent Désiré, Shawn S.C. Li, Stephan Stilgenbauer, Joshua D. Milner and Peter Gierschik

Oncotarget, 2018, 9, 34357
DOI: 10.18632/oncotarget.26173

GRB7 Expression and Correlation With HER2 Amplification in Invasive Breast Carcinoma

William W. Bivin, Oleksandr Yergiyev, Mark L. Bunker, Jan F. Silverman and Uma Krishnamurti

Applied Immunohistochemistry & Molecular Morphology, 2017, 25, 553
DOI: 10.1097/PAI.0000000000000349

Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies

Tim Kükenshöner, Nadine Eliane Schmit, Emilie Bouda, Fern Sha, Florence Pojer, Akiko Koide, Markus Seeliger, Shohei Koide and Oliver Hantschel

Journal of Molecular Biology, 2017, 429, 1364
DOI: 10.1016/j.jmb.2017.03.023

Development of an HPLC-UV Method for Quantification of Stattic

Soheil Sedaghat, Ommoleila Molavi, Akram Faridi, Ali Shayanfar and Mohammad Reza Rashidi

CPA, 2019, 15, 568
DOI: 10.2174/1573412914666180523092957

The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia

Yonglan Liu, Hyunbum Jang, Mingzhen Zhang, Chung-Jung Tsai, Ryan Maloney and Ruth Nussinov

Biophysical Journal, 2022, 121, 2251
DOI: 10.1016/j.bpj.2022.05.030

LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells

Xiang Chen, Li Pan, Jia Wei, Ruijie Zhang, Xiaozhi Yang, Jinhua Song, Ren-Yuan Bai, Shengling Fu, Christopher R. Pierson, Jonathan L. Finlay, Chenglong Li and Jiayuh Lin

Sci Rep, 2021, 11
DOI: 10.1038/s41598-021-85888-x

The GTPase-activating protein p120RasGAP has an evolutionarily conserved “FLVR-unique” SH2 domain

Rachel Jaber Chehayeb, Jessica Wang, Amy L. Stiegler and Titus J. Boggon

Journal of Biological Chemistry, 2020, 295, 10511
DOI: 10.1074/jbc.RA120.013976

ChemInform Abstract: Progress Towards the Development of SH2 Domain Inhibitors

Dziyana Kraskouskaya, Eugenia Duodu, Carolynn C. Arpin and Patrick T. Gunning

ChemInform, 2013, 44
DOI: 10.1002/chin.201326220

The role of the tyrosine kinase Lyn in allergy and cancer

Yizhao Sun, Yanlei Yang, Yang Zhao, Xiangsheng Li, Yanfen Zhang and Zhongcheng Liu

Molecular Immunology, 2021, 131, 121
DOI: 10.1016/j.molimm.2020.12.028

Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a

Nagarajan Elumalai, Angela Berg, Kalaiselvi Natarajan, Andrej Scharow and Thorsten Berg

Angewandte Chemie, 2015, 127, 4840
DOI: 10.1002/ange.201410672

Rhodium(II) Proximity‐Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti‐Leukemia Activity

Matthew B. Minus, Wei Liu, Farrukh Vohidov, Moses M. Kasembeli, Xin Long, Michael J. Krueger, Alexandra Stevens, Mikhail I. Kolosov, David J. Tweardy, Edward Allan R. Sison, Michele S. Redell and Zachary T. Ball

Angew Chem Int Ed, 2015, 54, 13085
DOI: 10.1002/anie.201506889

STAT3‐Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy

Jennifer E. Yeh and David A. Frank

ChemMedChem, 2016, 11, 795
DOI: 10.1002/cmdc.201500482

Crystal Structures and Thermodynamic Analysis Reveal Distinct Mechanisms of CD28 Phosphopeptide Binding to the Src Homology 2 (SH2) Domains of Three Adaptor Proteins

Satomi Inaba, Nobutaka Numoto, Shuhei Ogawa, Hisayuki Morii, Teikichi Ikura, Ryo Abe, Nobutoshi Ito and Masayuki Oda

Journal of Biological Chemistry, 2017, 292, 1052
DOI: 10.1074/jbc.M116.755173

Determination of promising inhibitors for N-SH2 domain of SHP2 tyrosine phosphatase: an in silico study

Emel Başak Gencer Akçok, Hüseyin Güner and İsmail Akçok

Mol Divers, 2024
DOI: 10.1007/s11030-024-10880-2

Biosensor Architectures for High-Fidelity Reporting of Cellular Signaling

Omer Dushek, Annemarie C. Lellouch, David J. Vaux and Vahid Shahrezaei

Biophysical Journal, 2014, 107, 773
DOI: 10.1016/j.bpj.2014.06.021

Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer Target

Gabrielle M. Watson, Ketav Kulkarni, Jianrong Sang, Xiuquan Ma, Menachem J. Gunzburg, Patrick Perlmutter, Matthew C.J. Wilce and Jacqueline A. Wilce

J. Med. Chem., 2017, 60, 9349
DOI: 10.1021/acs.jmedchem.7b01320

An auxiliary binding interface of SHIP2-SH2 for Y292-phosphorylated FcγRIIB reveals diverse recognition mechanisms for tyrosine-phosphorylated receptors involved in different cell signaling pathways

Zi Wang, Heng Zhou, Xiali Yue, Jiang Zhu, Yunhuang Yang and Maili Liu

Anal Bioanal Chem, 2022, 414, 497
DOI: 10.1007/s00216-021-03373-w

RNA interference in Haliotis rufescens myostatin evidences upregulation of insulin signaling pathway

Crisleri Carrera-Naipil, Valentina Valenzuela-Muñoz, Juan Antonio Valdés, Alfredo Molina and Cristian Gallardo-Escárate

Agri Gene, 2016, 1, 93
DOI: 10.1016/j.aggene.2016.07.004

Cloning, expression prolife, and immune characterization of a novel stat family member (stat5bl) in Chinese tongue sole (Cynoglossus semilaevis)

Min Wei, Wen-teng Xu, Tian Gan, Lei Wang, Hong-xiang Zhang, Fa-zhen Zhao and Song-lin Chen

Fish & Shellfish Immunology, 2019, 84, 962
DOI: 10.1016/j.fsi.2018.10.030

Targeted Covalent Inhibition of Grb2–Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells

Yongsheng Yu, Yunyu Nie, Qian Feng, Jiale Qu, Rui Wang, Liming Bian and Jiang Xia

Mol. Pharmaceutics, 2017, 14, 1548
DOI: 10.1021/acs.molpharmaceut.6b00952

Rhodium(II) Proximity‐Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti‐Leukemia Activity

Matthew B. Minus, Wei Liu, Farrukh Vohidov, Moses M. Kasembeli, Xin Long, Michael J. Krueger, Alexandra Stevens, Mikhail I. Kolosov, David J. Tweardy, Edward Allan R. Sison, Michele S. Redell and Zachary T. Ball

Angewandte Chemie, 2015, 127, 13277
DOI: 10.1002/ange.201506889

Direct cellular targets and anticancer mechanisms of the natural product oridonin

Jialin Yao, Lu Liu, Qingxiang Sun and Xiaofei Shen

MedComm – Future Medicine, 2023, 2
DOI: 10.1002/mef2.35

Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent

Daniel P. Ball, Andrew M. Lewis, Declan Williams, Diana Resetca, Derek J. Wilson and Patrick T. Gunning

Oncotarget, 2016, 7, 20669
DOI: 10.18632/oncotarget.7838

Halogen-substituted catechol bisphosphates are potent and selective inhibitors of the transcription factor STAT5b

Nagarajan Elumalai, Kalaiselvi Natarajan and Thorsten Berg

Bioorganic & Medicinal Chemistry, 2017, 25, 3871
DOI: 10.1016/j.bmc.2017.05.039

Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors

Robert A. Cerulli, Livia Shehaj, Isidora Tosic, Kevin Jiang, Jing Wang, David A. Frank and Joshua A. Kritzer

Bioorganic & Medicinal Chemistry, 2020, 28, 115542
DOI: 10.1016/j.bmc.2020.115542

Aucubin as a natural potential anti-acute hepatitis candidate: Inhibitory potency and hepatoprotective mechanism

Han Huang, Yuan-Hang Chang, Jian Xu, Hai-Yan Ni, Heng Zhao, Bo-Wen Zhai, Thomas Efferth, Cheng-Bo Gu and Yu-Jie Fu

Phytomedicine, 2022, 102, 154170
DOI: 10.1016/j.phymed.2022.154170

Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors

Jianpeng Guo, Wenying Yu, Guiping Cai, Wenda Zhang, Shanshan Li, Jiawen Zhu, Dongmei Song and Lingyi Kong

European Journal of Medicinal Chemistry, 2018, 151, 752
DOI: 10.1016/j.ejmech.2018.03.053

A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3

Xiaofei Shen, Lin Zhao, Peihao Chen, Yanqiu Gong, Dingdong Liu, Xia Zhang, Lunzhi Dai, Qingxiang Sun, Jizhong Lou, Zhong Jin, Baohua Zhang, Dawen Niu, Ceshi Chen, Xiangbing Qi and Da Jia

Journal of Biological Chemistry, 2019, 294, 17471
DOI: 10.1074/jbc.RA119.009801

Peptide Library Approach to Uncover Phosphomimetic Inhibitors of the BRCA1 C-Terminal Domain

E. Railey White, Luxin Sun, Zhong Ma, Jason M. Beckta, Brittany A. Danzig, David E. Hacker, Melissa Huie, David C. Williams, Ross A. Edwards, Kristoffer Valerie, J. N. Mark Glover and Matthew C. T. Hartman

ACS Chem. Biol., 2015, 10, 1198
DOI: 10.1021/cb500757u

Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment

Byung-Hak Kim, Eun Hee Yi and Sang-Kyu Ye

Arch. Pharm. Res., 2016, 39, 1085
DOI: 10.1007/s12272-016-0795-8

Protein Interaction Domains and Post-Translational Modifications: Structural Features and Drug Discovery Applications

Marian Vincenzi, Flavia Anna Mercurio and Marilisa Leone

CMC, 2020, 27, 6306
DOI: 10.2174/0929867326666190620101637

Pentafluorphosphato‐Phenylalanine: Amphiphile Phosphotyrosinmimetika mit Fluor‐spezifischen Proteinwechselwirkungen

Matteo Accorsi, Markus Tiemann, Leon Wehrhan, Lauren M. Finn, Ruben Cruz, Max Rautenberg, Franziska Emmerling, Joachim Heberle, Bettina G. Keller and Jörg Rademann

Angewandte Chemie, 2022, 134
DOI: 10.1002/ange.202203579

STAT3 Activation and Oncogenesis in Lymphoma

Fen Zhu, Kevin Boyang Wang and Lixin Rui

Cancers, 2019, 12, 19
DOI: 10.3390/cancers12010019

An Assay Based on SAMDI Mass Spectrometry for Profiling Protein Interaction Domains

Patrick T. O’Kane and Milan Mrksich

J. Am. Chem. Soc., 2017, 139, 10320
DOI: 10.1021/jacs.7b03805

Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein

Abbarna A. Cumaraswamy, Andrew M. Lewis, Mulu Geletu, Aleksandra Todic, Diego B. Diaz, Xin Ran Cheng, Carla E. Brown, Rob C. Laister, David Muench, Kagan Kerman, H. Leighton Grimes, Mark D. Minden and Patrick T. Gunning

ACS Med. Chem. Lett., 2014, 5, 1202
DOI: 10.1021/ml500165r

Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells

Christian Lis, Stefan Rubner, Martin Roatsch, Angela Berg, Tyler Gilcrest, Darwin Fu, Elizabeth Nguyen, Anne-Marie Schmidt, Harald Krautscheid, Jens Meiler and Thorsten Berg

Sci Rep, 2017, 7
DOI: 10.1038/s41598-017-17600-x

Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors

Steffanie L. Furtek, Christopher J. Matheson, Donald S. Backos and Philip Reigan

Oncotarget, 2016, 7, 77998
DOI: 10.18632/oncotarget.12868

Synthesis and structural characterization of a monocarboxylic inhibitor for GRB2 SH2 domain

Tao Xiao, Luxin Sun, Min Zhang, Zilu Li, Eric B. Haura, Ernst Schonbrunn and Haitao Ji

Bioorganic & Medicinal Chemistry Letters, 2021, 51, 128354
DOI: 10.1016/j.bmcl.2021.128354

Grb7-derived calmodulin-binding peptides inhibit proliferation, migration and invasiveness of tumor cells while they enhance attachment to the substrate

Juan Alcalde, María González-Muñoz and Antonio Villalobo

Heliyon, 2020, 6, e03922
DOI: 10.1016/j.heliyon.2020.e03922

Evaluation of the Interaction between Phosphohistidine Analogues and Phosphotyrosine Binding Domains

Tom E. McAllister, Katherine A. Horner and Michael E. Webb

ChemBioChem, 2014, 15, 1088
DOI: 10.1002/cbic.201402090

Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics

Carolyn C. Arpin, Stephen Mac, Yanlin Jiang, Huiwen Cheng, Michelle Grimard, Brent D.G. Page, Malgorzata M. Kamocka, Sina Haftchenary, Han Su, Daniel P. Ball, David A. Rosa, Ping-Shan Lai, Rodolfo F. Gómez-Biagi, Ahmed M. Ali, Rahul Rana, Helmut Hanenberg, Kagan Kerman, Kyle C. McElyea, George E. Sandusky, Patrick T. Gunning and Melissa L. Fishel

Molecular Cancer Therapeutics, 2016, 15, 794
DOI: 10.1158/1535-7163.MCT-15-0003

Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics

Taiwo Adesoye, Debasish Tripathy, Kelly K. Hunt and Khandan Keyomarsi

Cancers, 2024, 16, 492
DOI: 10.3390/cancers16030492

SH2 Domains Serve as Lipid-Binding Modules for pTyr-Signaling Proteins

Mi-Jeong Park, Ren Sheng, Antonina Silkov, Da-Jung Jung, Zhi-Gang Wang, Yao Xin, Hyunjin Kim, Pallavi Thiagarajan-Rosenkranz, Seohyeon Song, Youngdae Yoon, Wonhee Nam, Ilshin Kim, Eui Kim, Dong-Gyu Lee, Yong Chen, Indira Singaram, Li Wang, Myoung Ho Jang, Cheol-Sang Hwang, Barry Honig, Sungho Ryu, Justin Lorieau, You-Me Kim and Wonhwa Cho

Molecular Cell, 2016, 62, 7
DOI: 10.1016/j.molcel.2016.01.027

Targeting STAT3: A crucial modulator of sepsis

Wangrui Lei, Dianxiao Liu, Meng Sun, Chenxi Lu, Wenwen Yang, Changyu Wang, Ye Cheng, Meng Zhang, Mingzhi Shen, Zhi Yang, Yin Chen, Chao Deng and Yang Yang

Journal Cellular Physiology, 2021, 236, 7814
DOI: 10.1002/jcp.30394

Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target

Gabrielle M. Watson, William A. H. Lucas, Menachem J. Gunzburg and Jacqueline A. Wilce

Front. Mol. Biosci., 2017, 4
DOI: 10.3389/fmolb.2017.00064

Targeting lipid–protein interaction to treat Syk-mediated acute myeloid leukemia

Indira Singaram, Ashutosh Sharma, Shashank Pant, Muyun Lihan, Mi-Jeong Park, Melissa Pergande, Pawanthi Buwaneka, Yusi Hu, Nadim Mahmud, You-Me Kim, Stephanie Cologna, Vladimir Gevorgyan, Irum Khan, Emad Tajkhorshid and Wonhwa Cho

Nat Chem Biol, 2023, 19, 239
DOI: 10.1038/s41589-022-01150-z